trending Market Intelligence /marketintelligence/en/news-insights/trending/1oymocdrv8m2zduzegunaq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

NanoString raises $53.9M from public offering to fund gene research products

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


NanoString raises $53.9M from public offering to fund gene research products

NanoString Technologies Inc. said underwriters of its public offering have exercised their option to buy an additional 600,000 common shares.

The Seattle-based life sciences company offered a total of 4.6 million shares at $12.50 apiece to raise approximately $53.9 million in net proceeds, according to an Aug. 13 release. NanoString plans to use the proceeds to develop its digital spatial profiling platform and continued commercialization of its nCounter portfolio. Additional proceeds will be used for general corporate purposes and working capital.

J.P. Morgan and UBS Investment Bank acted as joint book-running managers, while Baird acted as lead manager for the offering.